ICAM1 and Insulin resistance: This response was associated with an improvement in lipoprotein profile and insulin resistance, coupled with a decrease in acute-phase inflammatory proteins, such as hs-CRP and C3, and a reduction in levels of pro-atherosclerotic molecules, such as PAI-1 and ICAM-1.